Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





ISOPROPYL GLYCIDYL								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 4016-14-2; **Chemical Formula:** C6H12O2
OSHA’s former limit for isopropyl glycidyl ether (IGE) was 50 ppm as an 8-hour TWA. The ACGIH has an 8-hour TWA of 50 ppm and a 15-minute STEL of 75 ppm for IGE. NIOSH (Ex. 8-47, Table N7) recommends a limit of 50 ppm as a 15-minute ceiling. OSHA proposed an 8-hour TWA of 50 ppm and a 15-minute STEL of 75 ppm for IGE, and these limits are established in the final rule. IGE is a colorless, volatile liquid.
The 4-hour LC(50) for IGE in mice was 1500 ppm and the 8-hour LC(50) in rats was 1100 ppm (Hine, Kodama, Wellington et al. 1956/Ex. 1-331). The intragastric LD(50)s in mice and rats were 1.30 and 4.2 g/kg, respectively; in rabbits, the dermal LD(50) was 9.65 g/kg (Hine, Kodama, Wellington et al. 1956/Ex. 1-331). Fifty daily seven-hour exposures of rats to 400 ppm caused a reduced rate of weight gain, an increase in hemoglobin, a decrease in peritoneal fat, and, in some animals, emphysematous lungs and mottling of the liver (Hine, Kodama, Wellington et al. 1956/Ex. 1-331). Animals in this study also exhibited signs of ocular irritation and respiratory distress.
In humans, eye, nose, and upper respiratory irritation occurred in the technicians handling the animals in the Hine and co-workers (1956/Ex. 1-331) study; exposure levels were not specified. Dermatitis has also been reported in workers exposed to other glycidyl ethers during manufacture, and one such case involved IGE exposure (ACGIH 1986/Ex. 1-3, p. 340).
In the final rule, OSHA is retaining the 8-hour TWA of 50 ppm and adding a 15-minute STEL of 75 ppm for IGE. The Agency concludes that both the TWA and STEL are necessary to reduce the risk to workers of chronic organ effects, such as those demonstrated to occur in animals (Hine, Kodama, Wellington et al. 1956/Ex. 1-331), and the significant risk of eye, skin, and upper respiratory tract irritation associated with short-term IGE exposures at the levels permitted in the absence of a short-term limit. OSHA considers sensory irritation, dermatitis, and chronic organ effects to be material impairments of health.
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue